2 completed, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow SCM Lifescience Co., LTD.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis SCM-AGH, Placebo - Dermatitis, Atopic | Phase 1 / Phase 2 | Completed | SCM Lifescience Co., LTD. | 92 | 2020-03-24 | 2023-06-08 |
| Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis SCM-AGH, Placebo - Pancreatitis, Acute | Phase 1 / Phase 2 | Completed | SCM Lifescience Co., LTD. | 36 | 2019-08-12 | 2023-06-08 |
| Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease SCM-CGH, Placebo - Chronic Graft-versus-host-disease | Phase 2 | Unknown | SCM Lifescience Co., LTD. | 84 | 2016-09-28 | 2023-06-08 |
Bronchiolitis Obliterans Syndrome (1) · Dermatitis, Atopic (1) · Pancreatitis (1)
South Korea (3)
Gwang Seong Choi, MD-Ph.D (1) · Yun Nah Lee (1)